• HIGHLIGHTS
- Repeated variable stress in rats induced urinary frequency, mechanical hypersensitivity, elevated plasma catecholamines and cortisol, bladder remodeling, and paraventricular nucleus (PVN) activation.
- Chronic oxytocin normalized intercontraction intervals, reduced stress hormones and PVN c-Fos, and increased central oxytocin receptor and glutamate decarboxylase 1 expression.
- Oxytocin appears to act mainly through central stress-responsive circuits rather than peripheral inflammation.
INTRODUCTION
Psychological stress contributes to lower urinary tract symptoms (LUTS), including urinary frequency, urgency, and bladder pain. Clinical studies indicate that daily stress exacerbates symptoms in patients with interstitial cystitis/bladder pain syndrome and urologic chronic pelvic pain, supporting a close association between stress and urinary dysfunction [
1-
3].
Experimental stress models show that psychological stress disrupts the autonomic and sensory pathways that control micturition. Water-avoidance stress and related paradigms induce epithelial alterations, mast-cell activation, neuroplastic changes, increased afferent excitability, and bladder hyperalgesia [
4-
8]. Stress also activates central stress circuits, particularly the hypothalamic paraventricular nucleus (PVN), which integrates autonomic, endocrine, and behavioral responses [
9]. These findings suggest that alterations in central stress processing may contribute to bladder dysfunction through the brain-bladder axis [
10].
Oxytocin (OXT) is a hypothalamic neuropeptide shown to have anxiolytic and analgesic effects through central neuromodulatory mechanisms. Administered systemically or centrally, OXT attenuates stress-related nociceptive responses and can influence autonomic output [
11,
12]. The OXT receptor (OXTR) is expressed in both stress-regulatory brain regions and the bladder. Previous studies reported reductions in bladder pressure following intravesical or intravenous OXT administration, suggesting that OXT may modulate urinary function [
13,
14]. However, it remains unclear whether OXT directly mediates stress-related bladder dysfunction or more broadly modulates stress-responsive circuits.
Despite these observations, how OXT signaling links central stress pathways to peripheral bladder function remains incompletely understood. Most previous studies have examined bladder physiology and central stress pathways separately; few have assessed both within the same defined stress model.
Repeated variable stress (RVS) is a validated model of unpredictable psychological stress that reproducibly induces physiological and behavioral alterations relevant to stress-exacerbated LUTS.
This preclinical mechanistic study therefore evaluated whether chronic OXT administration modulates bladder dysfunction in rats exposed to RVS and characterized associated changes in peripheral bladder tissues and central stress-related pathways. The aim was to explore coordinated functional and molecular changes in the stress-responsive brain-bladder axis, without seeking to establish definitive receptor-level causality.
MATERIALS AND METHODS
Animals and Study Design
Forty-two female Sprague-Dawley rats (200–230 g) were randomly allocated to control, stress, or stress/OXT groups (n=14 per group). Behavioral, cystometric, and blood analyses were performed in 8 rats per group. The remaining 6 rats per group were allocated to tissue analyses: 3 rats per group were used for both bladder histology and brain c-Fos immunohistochemistry, and the other 3 rats per group were used for reverse transcription quantitative polymerase chain reaction (RT-qPCR) of both bladder and brain tissues. Histological and molecular assays were performed in separate animals. All procedures were approved by the Institutional Animal Care and Use Committee of Southern Knights’ Laboratory (SKL2021003). Experiments were conducted at the Okinawa Life Science Research Center (registration number: A2021005). Rats were housed at a controlled temperature of 22°C±2°C under a 12-hour light/dark cycle, with free access to food and water.
OXT Administration
OXT (0.6 U/day; ASKA Pharmaceutical Co., Ltd., Japan) was administered continuously via subcutaneous osmotic pumps (ALZET model 2002). The delivery rate was 0.5 μL/hr, as specified by the manufacturer. Rats in the control and stress groups received pumps containing saline. Experiments began 2 days after pump implantation.
RVS Model
The stress and stress/OXT groups underwent one week of RVS involving oscillation, forced swimming, foot shock, and restraint; stressors were administered once daily in a randomized order to prevent habituation [
14].
Electronic von Frey Test
Mechanical sensitivity was assessed with an electronic von Frey anesthesiometer (model BIO-EVF, BIOSEB, France). A rigid tip was applied perpendicular to the plantar surface of the hind paw, and the force required to elicit withdrawal was recorded automatically. The mean of 2 measurements was calculated for each rat. Rats were allowed at least 30 minutes to acclimatize to the testing environment before measurements began. Stimuli were delivered at least 5 minutes apart to avoid sensitization. In accordance with standard protocols, the cutoff force was set at 60 g to prevent tissue injury and excessive stimulation.
Continuous Cystometry
Cystometry was performed under urethane anesthesia, administered at 0.4 g/kg intraperitoneally and 0.8 g/kg subcutaneously. A PE-50 catheter was inserted into the bladder for saline in-fusion at 3 mL/hr. Intercontraction interval, baseline pressure, threshold pressure, maximum pressure, and residual volume were recorded.
Measurement of Plasma Monoamines and Cortisol
Blood was collected from the inferior vena cava after cystometry. Standard assays were used to measure plasma levels of adrenaline, noradrenaline, dopamine, serotonin, and cortisol.
Histological and Immunohistochemical Analyses
Bladders and brains from 3 rats per group were fixed in 4% paraformaldehyde, embedded in paraffin, and cut into 4-μm sections. Bladder tissue was evaluated using hematoxylin and eosin staining and protein gene product 9.5 (PGP9.5) immunostaining. Neuronal activation in the PVN was assessed by c-Fos immunohistochemistry (Abcam, UK).
RT-qPCR Analysis
The bladder, the brainstem, and a single tissue block containing the thalamus and hypothalamus were collected from 3 rats per group. The thalamus and hypothalamus were not dissected separately; the block was analyzed as one sample per animal. RNA was extracted (Qiagen, The Netherlands) and complementary DNA was synthesized (Takara Bio, Japan) according to the manufacturers’ protocols. Expression levels were normalized to GAPDH and analyzed by the 2
−ΔΔCt method, with reactions performed in triplicate. Bladder targets were prostaglandin E receptor 3 (EP3), epithelial sodium channel (ENaC), and interleukin-6 (IL-6); brain targets were OXTR, corticotropin-releasing factor (CRF), choline acetyltransferase (ChAT), tyrosine hydroxylase (TH), glutamate decarboxylase 1 (GAD1), and CRF receptor 2 (CRFR2). These targets were selected on the basis of CRF-mediated stress-induced bladder dysfunction [
5,
6] and OXT-related neural modulation [
12,
13].
Table 1 lists the primer sequences.
Statistical Analysis
Data are presented as the mean±standard error of the mean. Comparisons were performed using 1-way analysis of variance followed by Fisher protected least significant difference post hoc test. Statistical significance was defined as P<0.05.
RESULTS
General Condition and Pain Sensitivity
General appearance and body weight showed no overt differences among the 3 groups (
Fig. 1A). Mechanical sensitivity differed significantly among groups. Compared with controls, rats in the stress group had a lower withdrawal threshold (26.2±2.1 g vs. 31.4±0.8 g, P<0.05) (
Fig. 1B). The stress/OXT group had an intermediate threshold (28.9±1.1 g) that did not differ significantly from that in either other group.
Bladder Function
During continuous cystometry, intercontraction intervals were significantly shorter in the stress group than in the control group (12.9±0.9 minutes vs. 18.2±1.3 minutes, P<0.05) (
Fig. 1C). No significant differences among groups were found in baseline pressure, threshold pressure, maximum contraction pressure, or residual volume (
Fig. 1D–F). In the stress/OXT group, intercontraction intervals were comparable to those in the control group.
Plasma Biomarkers
Measurements of plasma catecholamines and cortisol indicated physiological responses to stress (
Fig. 2). Compared with controls, rats in the stress group had higher plasma adrenaline (15.3±1.8 ng/mL vs. 9.5±2.5 ng/mL, P<0.05), dopamine (0.07±0.03 ng/mL vs. 0.03±0.01 ng/mL, P<0.05), and cortisol levels (0.81±0.04 μg/dL vs. 0.61±0.03 μg/dL, P<0.01). Noradrenaline levels did not differ significantly between the control and stress groups, but were lower in the stress/OXT group than in the stress group (P<0.05). Plasma serotonin levels tended to be lower in the stress group, but the difference was not statistically significant. The stress/OXT group had values similar to those in the control group.
Bladder Weight and Histology
The stress group had a significantly higher bladder weight than the control group (102.2±4.0 mg vs. 89.2±5.2 mg, P<0.05). Bladder weight in the stress/OXT group was intermediate (97.7±4.6 mg) and did not differ significantly from that in either other group. Histological examination showed a thicker transitional epithelium, lamina propria, and submucosa in the stress group than in controls (
Fig. 3A–C). Epithelial thickening was less pronounced in the stress/OXT group. PGP9.5 immunostaining revealed dense submucosal nerve fibers in the stress group (
Fig. 3E); these were absent in controls (
Fig. 3D) and reduced in the stress/OXT group (
Fig. 3F).
c-Fos Expression in the Hypothalamus
Immunohistochemistry showed more c-Fos–positive cells in the PVN of rats in the stress group than in controls (206±12 cells vs. 130±4 cells, P<0.001) (
Fig. 3G, H). The stress/OXT group had significantly fewer c-Fos–positive neurons (120±7 cells,
Fig. 3I), with counts similar to those in controls.
Gene Expression
Brainstem expression of ChAT (P<0.05), CRF (P<0.01), and TH (P<0.05) was higher in the stress group than in controls, whereas OXTR expression was higher in the stress/OXT group than in both other groups (P<0.01) (
Fig. 4A). In the combined thalamus-hypothalamus sample, OXTR and GAD1 expression was significantly higher in the stress/OXT group than in either the control or stress group (P<0.01) (
Fig. 4B). Both the stress and stress/OXT groups had higher CRFR2 expression than controls (P<0.01). In the bladder, stress increased messenger RNA (mRNA) levels of EP3 and ENaC relative to controls (P<0.05 for both). IL-6 expression was lower in the stress/OXT group than in the stress group (P<0.01), although it did not differ between the control and stress groups (
Fig. 4C).
DISCUSSION
This study demonstrated that RVS induced coordinated systemic, peripheral, and central alterations: lower mechanical pain thresholds, shorter intercontraction intervals, elevated plasma catecholamines and cortisol, increased bladder weight, epithelial thickening, submucosal nerve hyperplasia, and upregulated EP3 and ENaC mRNA expression. Stress also increased c-Fos–positive neuronal activity in the hypothalamic PVN and upregulated brainstem ChAT, CRF, and TH expression. These findings are consistent with a possible effect of psychological stress on bladder function through integrated mechanisms of the brain-bladder axis.
Chronic OXT administration attenuated several stress-induced functional and molecular changes and was associated with increased OXTR and GAD1 expression in central regions. These findings suggest enhanced inhibitory signaling in stressresponsive neural circuits. Although OXT normalized intercontraction intervals and reduced central stress markers, it only partially improved mechanical hypersensitivity. This difference may indicate that micturition control and bladder nociception depend on partially distinct neural substrates, with peripheral or spinal mechanisms contributing to stress-induced hyperalgesia that may be less sensitive to OXT modulation.
Repeated psychophysical stress is known to induce hyperalgesia [
15], increase urinary frequency together with catecholamine and cortisol levels [
5,
6], and activate the PVN [
9]. These established responses mirror the present findings and support the RVS model as a means of reproducing stress-exacerbated lower urinary tract dysfunction.
Stress increased bladder EP3 and ENaC expression, potentially contributing to changes in prostaglandin signaling, epithelial ion transport, and sensory regulation. OXT tended to attenuate these expression changes, although the effects were not consistently statistically significant. IL-6 expression did not increase with stress and was reduced only in OXT-treated animals. This finding suggests that peripheral inflammatory signaling is unlikely to be the primary mediator of stress-induced urinary frequency in this model. The overall pattern is more consistent with predominant central modulation than with direct peripheral inflammatory involvement.
In the brainstem, CRF expression was significantly lower in the stress/OXT group than in the stress group, whereas ChAT and TH expression in the stress/OXT group did not differ significantly from that in either the control or stress group. CRF signaling has been implicated in stress-related autonomic and micturition modulation through glutamatergic pathways mediated by CRF receptors [
6,
16], while cholinergic and catecholaminergic systems contribute to pontine coordination of voiding and storage [
11,
12]. The reduction in CRF expression may thus be one mechanism through which OXT influences stress-associated bladder hyperactivity. Increased GAD1 expression also suggests enhanced gamma-aminobutyric acid-mediated inhibitory tone in hypothalamic and thalamic regions, consistent with the established anxiolytic and neuromodulatory properties of OXT [
17-
19]. Previous reviews have examined stress-related CRF circuits and their integration with central autonomic regulation in detail [
20].
These coordinated central changes are consistent with involvement of OXT–CRF-autonomic pathways, but the study did not examine direct receptor-level causality. Functional improvement occurred alongside changes in OXTR and CRFR2 expression; however, establishing causal mechanisms will require definitive verification with receptor-specific antagonists or site-specific interventions, such as OXTR blockade, CRF receptor inhibition, or PVN-targeted approaches.
Whether OXT acts primarily through central or peripheral mechanisms also warrants consideration. In this study, OXT was used to pharmacologically modulate stress-responsive neural circuits, rather than to replace an assumed endogenous deficiency. Systemically administered OXT may affect central circuits indirectly or through limited penetration of the bloodbrain barrier, whereas peripheral OXTR expression suggests possible direct effects on the bladder [
13,
14]. The suppression of PVN activation and enhancement of central inhibitory markers in this model suggest that central neuromodulatory effects likely play a major role, although peripheral contributions cannot be excluded.
Anesthesia can influence autonomic and neuroendocrine measurements. Urethane was selected because it preserves bladder reflex activity and has minimal hemodynamic effects; these properties account for its widespread use in rodent cystometry with preserved micturition reflexes, as described in previous lower urinary tract research [
21,
22]. They also support its use for functional bladder assessment in this model. Nevertheless, endocrine measurements obtained under anesthesia should be interpreted with caution.
Without an OXT-only group, stress-specific effects cannot be definitively distinguished from general pharmacological effects; future studies should address this limitation.
This study investigated preclinical mechanisms in a defined stress model and did not provide definitive therapeutic validation. In this setting, the findings are consistent with a possible role for OXT in modulating stress-responsive neural circuits associated with bladder function. Together, these findings provide an integrated neurobiological perspective on stress-related bladder dysfunction and identify OXT signaling as a candidate pathway for further mechanistic investigation.